title: Synergism of castanospermine and FK 506.
authors.affiliation: Newcastle Transplant Unit, John Hunter Hospital, NSW, Australia.
authors.forename: P M
authors.initials: PM
authors.lastname: Grochowicz
authors.forename: A D
authors.initials: AD
authors.lastname: Hibberd
authors.forename: K M
authors.initials: KM
authors.lastname: Bowen
authors.forename: D A
authors.initials: DA
authors.lastname: Clark
authors.forename: G
authors.initials: G
authors.lastname: Pang
authors.forename: L K
authors.initials: LK
authors.lastname: Grochowicz
authors.forename: D O
authors.initials: DO
authors.lastname: Willenborg
authors.forename: W B
authors.initials: WB
authors.lastname: Cowden
mesh_terms: D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology*; D006650:Histocompatibility Testing; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007212:Indolizines / Q000008:administration & dosage / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007959:Lymphocyte Culture Test, Mixed; D008285:Major Histocompatibility Complex; D016016:Proportional Hazards Models; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D054836:Indolizidines
chemical_list: D007166:Immunosuppressive Agents; D007212:Indolizines; D016559:Tacrolimus; C037806:castanospermine; D054836:Indolizidines